vanadyl sulfate has been researched along with Diabetes Mellitus in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mehdi, MZ; Srivastava, AK | 1 |
| Dantzer, R; Freund, GG; Johnson, DR; O'Connor, JC | 1 |
| Kelemen, A; Liang, Y; Tayo, B | 1 |
| Cohen, N; Halberstam, M; Rossetti, L; Shamoon, H; Shlimovich, P | 1 |
| Leckström, A; Shafrir, E; Westermark, P; Ziv, E | 1 |
1 review(s) available for vanadyl sulfate and Diabetes Mellitus
| Article | Year |
|---|---|
Vanadium (vanadyl sulfate). Monograph.
Topics: Animals; Clinical Trials as Topic; Diabetes Mellitus; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Humans; Hypoglycemic Agents; Vanadium Compounds | 2009 |
1 trial(s) available for vanadyl sulfate and Diabetes Mellitus
| Article | Year |
|---|---|
Oral vanadyl sulfate improves insulin sensitivity in NIDDM but not in obese nondiabetic subjects.
Topics: Administration, Oral; Blood Glucose; Blood Pressure; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Female; Glucose Clamp Technique; Glycated Hemoglobin; Glycolysis; Humans; Hypoglycemic Agents; Infusions, Intravenous; Insulin; Kinetics; Lactates; Male; Middle Aged; Obesity; Reference Values; Regression Analysis; Triglycerides; Vanadium Compounds | 1996 |
4 other study(ies) available for vanadyl sulfate and Diabetes Mellitus
| Article | Year |
|---|---|
Organo-vanadium compounds are potent activators of the protein kinase B signaling pathway and protein tyrosine phosphorylation: mechanism of insulinomimesis.
Topics: Animals; Blood Glucose; Cells, Cultured; CHO Cells; Cricetinae; Diabetes Mellitus; Glycogen Synthase Kinase 3; Hypoglycemic Agents; Insulin; Insulin Resistance; Organometallic Compounds; Phosphorylation; Protein Serine-Threonine Kinases; Protein Tyrosine Phosphatases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Signal Transduction; Tyrosine; Vanadium Compounds | 2005 |
Inhibition of vagally mediated immune-to-brain signaling by vanadyl sulfate speeds recovery from sickness.
Topics: Animals; Brain; Cells, Cultured; Cholecystokinin; Diabetes Mellitus; Eating; Exploratory Behavior; Humans; Hypoglycemic Agents; Immune System; Insulin-Like Growth Factor I; Interleukin 1 Receptor Antagonist Protein; Interleukin-1; Interleukin-6; Lipopolysaccharides; Macrophages, Peritoneal; Male; Mice; Sialoglycoproteins; Signal Transduction; Tumor Necrosis Factor-alpha; Vagus Nerve; Vanadium Compounds | 2005 |
Model-based or algorithm-based? Statistical evidence for diabetes and treatments using gene expression.
Topics: Algorithms; Animals; Diabetes Mellitus; Evidence-Based Medicine; Gene Expression; Microarray Analysis; Rats; United States; Vanadium Compounds | 2007 |
Islet amyloid polypeptide in Psammomys obesus (sand rat): effects of nutritionally induced diabetes and recovery on low-energy diet or vanadyl sulfate treatment.
Topics: Amyloid; Animals; Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diet; Female; Gerbillinae; Hyperglycemia; Hyperinsulinism; Hypoglycemic Agents; Immunohistochemistry; Insulin; Islet Amyloid Polypeptide; Islets of Langerhans; Obesity; Vanadium Compounds | 1997 |